Report on a preclinical study showing a psychedelic compound prevented chemotherapy-induced peripheral neuropathy in mice by acting on sensory nerves.
Key Takeaways
- Just two doses of psilocybin administered before chemotherapy completely prevented mice from developing neuropathy
- Condition affects as many as 60% of people treated with platinum-based cancer drugs
- Depleted of energy, the neurons’ tips degenerate, dulling tactile sensation and sparking chronic pain